Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Thailand: Three...

    Thailand: Three Companies try to patent medical marijuana, applications suspended

    Farhat NasimWritten by Farhat Nasim Published On 2019-02-01T09:25:57+05:30  |  Updated On 1 Feb 2019 9:25 AM IST
    Thailand: Three Companies try to patent medical marijuana, applications suspended

    Bangkok: Thailand's military government on Monday suspended the licensing of commercial marijuana-based products for medical use amid concern that foreign pharmaceutical companies might try to monopolise the market.


    Prime Minister Prayuth Chan-ocha's decree orders the director of the Department of Intellectual Property to invalidate all patent applications for medical marijuana products, declaring that for the time being commercial products from marijuana or having the same molecular structure as the plant are not supported under intellectual property laws.




    The decree says it will remain in effect until legislation on medical marijuana comes into force. Parliament last month legalized the regulated use of medical marijuana but the legislation must be signed by King Maha Vajiralongkorn to become law. At that point, new applications are expected to be allowed that meet conditions specified under the law.


    Read Also: Thailand’s legislature legalizes medical use of marijuana


    The order was issued under special powers the military government that seized power in 2014 gave itself to implement laws without approval from Parliament.


    The move came in response to concerns that foreign companies could monopolise the medical marijuana industry, as some had already registered for patents to produce medical marijuana in Thailand, said Arun Max Avery, chief operating officer for Highland, a marijuana advocacy group.


    Avery said foreign companies such as Britain's GW Pharmaceuticals and Japan's Otsuka Pharmaceutical had filed patents to produce medical marijuana and although their applications have not been approved, they have also not been rejected.


    Avery said the two companies had "already established themselves in North America and Europe and now they're making their move in Thailand." Avery said part of the concern over the foreign companies' patent applications was that Thai intellectual property law does not allow natural substances to be patented.


    He said the move to sideline the patent applications and wait for the new law might result in conditions making it possible for more Thais to cultivate and consume medical marijuana.


    On December 25 last year, Thailand's legislature agreed to amend the country's drug law to allow the licensed medical use of marijuana, as well as kratom, a locally grown plant traditionally used as a stimulant and painkiller.

    Arun Max AveryBangkokBritains GW PharmaceuticalsJapans Otsuka PharmaceuticalKing Maha VajiralongkornkratomlicensingmarijuanaMedical marijuanamedical marijuana productsmonopolisepainkillerpatentPrayuth Chan ochasuspendsThailand
    Source : AP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok